Purchase Order HHSN275201600642P
Award Date 8/15/16
Potential Completion Date 11/30/16
Potential Value $117K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Exton, PA 19341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $117,000.00 firm fixed price purchase order awarded to Frontage Laboratories, Inc. by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The contract is for Frontage Laboratories to provide a range of preclinical research services, including pharmacokinetic testing, in vivo studies, compound synthesis, and fertility assessments, to support the development of new therapies and...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. for $126,850.00. The contract is for research services related to the "Blood Stability and Metabolism of MTS-IV-39 Analogs." This work supports NIDDK's research program and was not set aside for any specific business category. Frontage Laboratories is a full-service contract...
- This is a $19,000 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO). The contract is for the synthesis of SAMT-247 and an analog compound. Frontage Laboratories has previously supported NIDDK and the National Center for Advancing Translational Sciences through various federal contracts, providing services such as pharmacokinetic testing, in...
- The National Institutes of Health awarded a $36.2K purchase order to Frontage Laboratories, Inc., a minority-owned, Asian-Pacific American owned business, for method development validation work under POTS# 09-030459. The contract, issued on May 22, 2009, with an ultimate completion date of May 21, 2010, was executed at firm fixed price with no set-aside designation, indicating the contractor competed successfully in an open bidding process. Work was performed at Frontage Laboratories' facility...
- This federal contract award is for the synthesis of Fmoc-thyclotide monomers, placed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) with the prime contractor Frontage Laboratories, Inc. The $45,500.00 firm-fixed-price purchase order has an ultimate completion date of December 31, 2020. Frontage Laboratories, a minority-owned, Asian-Pacific American-owned business, has an established history of providing specialized research services to NIDDK and other NIH...
- This is a $34,000.00 firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO), for an intravaginal female fertility study. The contract will run through January 5, 2024. Frontage Laboratories has previously conducted a range of preclinical research services for NIDDK and the National Center for Advancing Translational Sciences, including...
- This is a $162,000 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO), for the synthesis of thyclotides and cyclopentane-constrained peptide nucleic acids. The award was made on a sole-source basis under simplified acquisition procedures, as Frontage was determined to be the only source capable of scaling up the production of these...
- The National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $90,000.00 firm fixed price purchase order contract to Frontage Laboratories, Inc. for the synthesis of thyclotides (R,R). The contract has no set-aside designation and was awarded on August 14, 2022 with an ultimate completion date of August 17, 2023. Frontage Laboratories, a minority-owned, Asian-Pacific American manufacturer of goods, has provided a range of research...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a purchase order to Frontage Laboratories, Inc. for $222,500 on July 21, 2026, under a Total Small Business set-aside. Work is performed in Exton, Pennsylvania. The order is firm fixed price with an ultimate completion date of July 20, 2027.</p>
- The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $18,000 purchase order to Frontage Laboratories, Inc. for blood stability studies. Frontage Laboratories, the prime contractor, will perform the studies at its facility located in Exton, Pennsylvania over a two-month period concluding in early October 2018. The contract is a firm fixed price award to support the funding agency's research into...